股東會相關資料

GWOXI Stem Cell Enters Japan to Expand International Regenerative Medicine Business, Pushing to Internationalize Adipose Stem Ce

GWOXI Stem Cell Makes a Preemptive Strategic Move to Address the Dual Challenges of Population Aging and Younger-Onset Stroke.

GWOXI's New Stem Cell Drug for Osteoarthritis Approved to Start a Phase III Clinical Trial in Taiwan.